4//SEC Filing
Townsend Scott B 4
Accession 0001179110-13-003998
CIK 0000792977other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:34 PM ET
Size
9.4 KB
Accession
0001179110-13-003998
Insider Transaction Report
Form 4
Townsend Scott B
SVP, General Counsel
Transactions
- Award
Common Stock
2013-02-28+7,500→ 11,900 total - Award
Common Stock
2013-02-28+4,400→ 4,400 total - Award
Stock Option (Right to Buy)
2013-02-28+26,300→ 26,300 totalExercise: $16.55Exp: 2023-02-28→ Common Stock (26,300 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of restricted stock units (an "RSU Grant") pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) in equal annual installments over the next three years thereafter.
- [F3]Not applicable.
- [F4]These shares of Common Stock are issuable pursuant to a market-based RSU Grant under the Plan and will vest, if at all, based on achievement of certain target performance of the Issuer's stock price at the end of the three-year period ending December 31, 2015. The number represents the maximum number of shares that may be delivered pursuant to the award.
- [F5]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% vesting on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeother
Related Parties
1- filerCIK 0001303192
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:34 PM ET
- Size
- 9.4 KB